Corbus Pharmaceuticals (CRBP) - התחייבויות לטווח ארוך להון

This chart of the current market value of Corbus Pharmaceuticals (CRBP) reflects the dynamics of a company developing advanced treatments for inflammatory processes and fibrosis by targeting the endocannabinoid system. The business relies on the development of immunotherapy and targeted drugs for resistant forms of cancer, where a diverse range of lung treatment programs protects assets. The current figure stands at 0.03, while the structure has minimized past risks by focusing on precision oncology.

This ratio determines the share of long-term liabilities within the equity structure, allowing for an assessment of the company's financial leverage stability over a horizon exceeding one year. By analyzing the dynamics of the long-term financial dependency ratio, an investor can discern the balance between debt capital and assets, which is critically important for Corbus Pharmaceuticals (CRBP) when financing complex logistics chains and strict temperature controls for the delivery of oncology drugs.